TP53 and ovarian carcinoma: Interestingly, when cell cycle response to EpoB of the primary ovarian cancer cell line SS6 bearing mutation on p53 (Figure 2B) is compared to the response of the immortalized p53−/− null cell line SKOV3 also carrying p53 mutations (Figure 3), an opposite effect can be observed.